EP3476391A4 - Composition pour médicament - Google Patents

Composition pour médicament Download PDF

Info

Publication number: EP3476391A4
Authority: EP; European Patent Office
Prior art keywords: medication; composition
Prior art date: 2016-06-23
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

EP17815505.7A

Other languages

German (de)

English (en)

Other versions

EP3476391A1 (fr

EP3476391B1 (fr

Inventor

Yoshitaka Nagai

Helena Akiko POPIEL

Eiko MINAKAWA

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Japan Science and Technology Agency

Original Assignee

Japan Science and Technology Agency

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2016-06-23

Filing date

2017-06-23

Publication date

2020-03-04

2017-06-23 Application filed by Japan Science and Technology Agency filed Critical Japan Science and Technology Agency

2019-05-01 Publication of EP3476391A1 publication Critical patent/EP3476391A1/fr

2020-03-04 Publication of EP3476391A4 publication Critical patent/EP3476391A4/fr

2021-08-11 Application granted granted Critical

2021-08-11 Publication of EP3476391B1 publication Critical patent/EP3476391B1/fr

Status Active legal-status Critical Current

2037-06-23 Anticipated expiration legal-status Critical

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Epidemiology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Psychology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

EP17815505.7A 2016-06-23 2017-06-23 Composition pharmaceutique comprenant de l'arginine pour l'utilisation dans le traitement de la maladie de polyq Active EP3476391B1 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2016124992		2016-06-23
PCT/JP2017/023162 WO2017222040A1 (fr)	2016-06-23	2017-06-23	Composition pour médicament

Publications (3)

Publication Number	Publication Date
EP3476391A1 EP3476391A1 (fr)	2019-05-01
EP3476391A4 true EP3476391A4 (fr)	2020-03-04
EP3476391B1 EP3476391B1 (fr)	2021-08-11

Family

ID=60783349

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP17815505.7A Active EP3476391B1 (fr)	2016-06-23	2017-06-23	Composition pharmaceutique comprenant de l'arginine pour l'utilisation dans le traitement de la maladie de polyq

Country Status (7)

Country	Link
US (1)	US20190314311A1 (fr)
EP (1)	EP3476391B1 (fr)
JP (1)	JP6933380B2 (fr)
CN (1)	CN109310659B (fr)
ES (1)	ES2896224T3 (fr)
PT (1)	PT3476391T (fr)
WO (1)	WO2017222040A1 (fr)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20040152778A1 (en) *	2003-01-17	2004-08-05	Brusilow William S.	Treatment of polyglutamine disorders caused by expanding genomic CAG nucleotides

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10016527A1 (de) *	2000-04-03	2001-10-18	Max Planck Gesellschaft	Verfahren zur Diagnose von Krebserkrankungen und/oder neurodegenerativen Krankheitszuständen sowie Produkte dafür
US20040235733A1 (en) *	2003-02-27	2004-11-25	Steffan Joan S.	Methods and reagents for reducing polyglutamine toxicity
WO2013061161A2 (fr) *	2011-10-28	2013-05-02	Green Bcn Consulting Services Sl	Nouvelles polythérapies destinées au traitement de troubles neurologiques
JP6495270B2 (ja) *	2013-10-30	2019-04-03	ザユニバーシティオブウェスタンオーストラリア	神経保護ペプチドを含有する医薬組成物

2017
- 2017-06-23 WO PCT/JP2017/023162 patent/WO2017222040A1/fr not_active Ceased
- 2017-06-23 PT PT178155057T patent/PT3476391T/pt unknown
- 2017-06-23 EP EP17815505.7A patent/EP3476391B1/fr active Active
- 2017-06-23 US US16/312,208 patent/US20190314311A1/en not_active Abandoned
- 2017-06-23 ES ES17815505T patent/ES2896224T3/es active Active
- 2017-06-23 JP JP2018524177A patent/JP6933380B2/ja active Active
- 2017-06-23 CN CN201780038090.5A patent/CN109310659B/zh active Active

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20040152778A1 (en) *	2003-01-17	2004-08-05	Brusilow William S.	Treatment of polyglutamine disorders caused by expanding genomic CAG nucleotides

Also Published As

Publication number	Publication date
EP3476391A1 (fr)	2019-05-01
PT3476391T (pt)	2021-11-09
EP3476391B1 (fr)	2021-08-11
CN109310659A (zh)	2019-02-05
US20190314311A1 (en)	2019-10-17
ES2896224T3 (es)	2022-02-24
CN109310659B (zh)	2021-04-16
JPWO2017222040A1 (ja)	2019-04-18
JP6933380B2 (ja)	2021-09-08
WO2017222040A1 (fr)	2017-12-28

Legal Events

Date	Code	Title	Description
2017-12-29	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE
2019-03-29	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2019-03-29	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE
2019-05-01	17P	Request for examination filed	Effective date: 20190121
2019-05-01	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
2019-05-01	AX	Request for extension of the european patent	Extension state: BA ME
2019-10-02	DAV	Request for validation of the european patent (deleted)
2019-10-02	DAX	Request for extension of the european patent (deleted)
2020-03-04	A4	Supplementary search report drawn up and despatched	Effective date: 20200131
2020-03-04	RIC1	Information provided on ipc code assigned before grant	Ipc: A61P 25/14 20060101ALI20200127BHEP Ipc: A61P 25/00 20060101ALI20200127BHEP Ipc: A61P 21/02 20060101ALI20200127BHEP Ipc: A61P 25/28 20060101ALI20200127BHEP Ipc: A61P 21/00 20060101ALI20200127BHEP Ipc: A61K 31/198 20060101AFI20200127BHEP
2021-03-23	GRAP	Despatch of communication of intention to grant a patent	Free format text: ORIGINAL CODE: EPIDOSNIGR1
2021-03-23	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: GRANT OF PATENT IS INTENDED
2021-04-21	INTG	Intention to grant announced	Effective date: 20210324
2021-07-01	GRAS	Grant fee paid	Free format text: ORIGINAL CODE: EPIDOSNIGR3
2021-07-09	GRAA	(expected) grant	Free format text: ORIGINAL CODE: 0009210
2021-07-09	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE PATENT HAS BEEN GRANTED
2021-08-11	AK	Designated contracting states	Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
2021-08-16	REG	Reference to a national code	Ref country code: CH Ref legal event code: EP
2021-08-26	REG	Reference to a national code	Ref country code: DE Ref legal event code: R096 Ref document number: 602017043962 Country of ref document: DE
2021-09-15	REG	Reference to a national code	Ref country code: IE Ref legal event code: FG4D Ref country code: AT Ref legal event code: REF Ref document number: 1418659 Country of ref document: AT Kind code of ref document: T Effective date: 20210915
2021-11-09	REG	Reference to a national code	Ref country code: PT Ref legal event code: SC4A Ref document number: 3476391 Country of ref document: PT Date of ref document: 20211109 Kind code of ref document: T Free format text: AVAILABILITY OF NATIONAL TRANSLATION Effective date: 20211103
2021-12-01	REG	Reference to a national code	Ref country code: NL Ref legal event code: FP
2021-12-10	REG	Reference to a national code	Ref country code: LT Ref legal event code: MG9D
2022-01-15	REG	Reference to a national code	Ref country code: AT Ref legal event code: MK05 Ref document number: 1418659 Country of ref document: AT Kind code of ref document: T Effective date: 20210811
2022-01-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210811 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210811 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211111 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211111 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210811 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210811 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210811 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210811
2022-02-24	REG	Reference to a national code	Ref country code: ES Ref legal event code: FG2A Ref document number: 2896224 Country of ref document: ES Kind code of ref document: T3 Effective date: 20220224
2022-02-28	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210811 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210811 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211112
2022-04-29	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210811
2022-05-12	REG	Reference to a national code	Ref country code: DE Ref legal event code: R097 Ref document number: 602017043962 Country of ref document: DE
2022-06-01	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210811 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210811 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210811 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210811 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210811 Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210811
2022-06-17	PLBE	No opposition filed within time limit	Free format text: ORIGINAL CODE: 0009261
2022-06-17	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT
2022-07-20	26N	No opposition filed	Effective date: 20220512
2022-08-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210811
2023-01-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210811
2023-01-31	REG	Reference to a national code	Ref country code: CH Ref legal event code: PL
2023-02-20	REG	Reference to a national code	Ref country code: BE Ref legal event code: MM Effective date: 20220630
2023-04-28	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220623 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220630 Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220623 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220630
2023-05-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220630
2024-03-29	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20170623
2024-04-30	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210811 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210811
2024-06-28	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210811
2024-09-30	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210811
2025-06-17	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: NL Payment date: 20250508 Year of fee payment: 9
2025-07-09	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: DE Payment date: 20250508 Year of fee payment: 9
2025-07-10	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: GB Payment date: 20250508 Year of fee payment: 9
2025-07-15	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: IT Payment date: 20250512 Year of fee payment: 9
2025-07-17	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: PT Payment date: 20250509 Year of fee payment: 9
2025-07-18	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: FR Payment date: 20250513 Year of fee payment: 9
2025-10-09	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: ES Payment date: 20250714 Year of fee payment: 9

Publication	Publication Date	Title
EP3513809A4 (fr)	2020-06-03	Composition médicinale
MA41265A (fr)	2017-10-31	Compositions pour administration de médicaments iléo-jéjunal.
EP3347458A4 (fr)	2019-08-07	Cochon multi-transgénique pour xénogreffe
SI3529248T1 (sl)	2020-11-30	Farmacevtske spojine
DK3256138T3 (da)	2022-05-16	Farmaceutiske sammensætninger omfattende meloxicam
EP3630078A4 (fr)	2021-03-03	Agents pour chimio-embolisation
BR112016026879A2 (pt)	2017-08-15	Composição farmacêutica líquida
DK3655038T3 (da)	2025-02-17	Farmaceutisk sammensætning
DK3532029T3 (da)	2021-06-07	Flydende farmaceutisk sammensætning
DK3496551T3 (da)	2024-10-28	Flydende allulosesammensætning
FR3036518B1 (fr)	2018-07-06	Inversion pour contrainte tectonique
DK3529240T3 (da)	2020-09-07	Farmaceutiske forbindelser
EP3310439A4 (fr)	2019-02-20	Compositions pharmaceutiques pour des applications anesthésiologiques
DK3528902T3 (da)	2021-07-05	Ringegelsammensætning
DK3278801T3 (da)	2019-12-16	Farmaceutisk sammensætning indeholdende mirabegron
EP3590546A4 (fr)	2021-01-06	Composition pour injection cutanée
EP3305350A4 (fr)	2019-02-13	Ensemble filtre-aiguille pour seringue
DK3583943T3 (da)	2024-10-14	Farmaceutisk sammensætning
EP3479828A4 (fr)	2020-04-29	Composition médicamenteuse pour administration parentérale
EP3378585A4 (fr)	2019-06-26	Composition pour liaison
EP3394006A4 (fr)	2019-08-14	Accélérateur pour composition hydraulique
EP3364979A4 (fr)	2019-06-26	Composition pour moduler irak1
EP3725860A4 (fr)	2021-01-20	Composition pour encapsulation
SMT202400478T1 (it)	2025-01-14	Composizione farmaceutica
EP3443034C0 (fr)	2024-04-10	Composition